Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Oncogene

• Publication date

  2019-01-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41388-019-0690-0PMID 30664689PMCID PMC7568686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Template‐based and free modeling of I‐TASSER and QUARK pipelines using predicted contact maps in CASP12

  2018cited by this paper
• MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells

  2017cited by this paper
• EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion

  2017cited by this paper
• GalaxyRefineComplex: Refinement of protein-protein complex model structures driven by interface repacking

  2016cited by this paper
• I-TASSER server: new development for protein structure and function predictions

  2015cited by this paper
• Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival*

  2015cited by this paper
• ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers

  2014cited by this paper
• The I-TASSER Suite: protein structure and function prediction

  2014cited by this paper
• Mixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer.

  2013cited by this paper
• PAK signalling during the development and progression of cancer

  2013cited by this paper
• PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

  2013cited by this paper
• p21-Activated Kinase 1 (PAK1) Can Promote ERK Activation in a Kinase-independent Manner*

  2013cited by this paper
• Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

  2013cited by this paper
• PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation

  2012cited by this paper
• Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function

  2012cited by this paper
• Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling

  2012cited by this paper
• Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells

  2011cited by this paper
• Redesign of the PAK1 autoinhibitory domain for enhanced stability and affinity in biosensor applications.

  2011cited by this paper
• Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.

  2010cited by this paper
• Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons

  2010cited by this paper
• Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.

  2010cited by this paper
• I-TASSER: a unified platform for automated protein structure and function prediction

  2010cited by this paper
• A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

  2009cited by this paper
• Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1

  2009cited by this paper
• I-TASSER server for protein 3D structure prediction

  2008cited by this paper
• Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

  2008cited by this paper
• MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE

  2008cited by this paper
• Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

  2007cited by this paper
• Identification of phosphorylation sites in betaPIX and PAK1.

  2007cited by this paper
• Identification of phosphorylation sites in βPIX and PAK1

  2007cited by this paper
• Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae.

  2007cited by this paper
• Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.

  2006cited by this paper
• Paxillin phosphorylation at Ser273 localizes a GIT1–PIX–PAK complex and regulates adhesion and protrusion dynamics

  2006cited by this paper
• Discriminative topological features reveal biological network mechanisms

  2004cited by this paper
• TCR Engagement Induces Proline-Rich Tyrosine Kinase-2 (Pyk2) Translocation to the T Cell-APC Interface Independently of Pyk2 Activity and in an Immunoreceptor Tyrosine-Based Activation Motif-Mediated Fashion1

  2002cited by this paper
• Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.

  2002cited by this paper
• P21‐activated kinase‐1 phosphorylates and transactivates estrogen receptor‐α and promotes hyperplasia in mammary epithelium

  2002cited by this paper
• Signalling: Mixed-lineage kinase control of JNK and p38 MAPK pathways

  2002cited by this paper
• Emerging functions of p21‐activated kinases in human cancer cells

  2002cited by this paper
• The K252a Derivatives, Inhibitors for the PAK/MLK Kinase Family, Selectively Block the Growth of HAS Transformants

  2002cited by this paper
• Mixed lineage kinase 3 mediates gp120IIIB‐induced neurotoxicity

  2002cited by this paper
• Activation of the Drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3.

  2002cited by this paper
• The Mechanism of PAK Activation

  2001cited by this paper
• Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1.

  2000cited by this paper
• Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1*

  2000cited by this paper
• Mechanism of activation of Pak1 kinase by membrane localization

  1999cited by this paper
• The MAPKKK Ste11 regulates vegetative growth through a kinase cascade of shared signaling components.

  1999cited by this paper
• The p21Rac/Cdc42-activated kinases (PAKs).

  1998cited by this paper
• Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck.

  1997cited by this paper
• A 3-Mb contig from D11S987 to MLK3, a gene-rich region in 11q13.

  1997cited by this paper
• The Mixed Lineage Kinase SPRK Phosphorylates and Activates the Stress-activated Protein Kinase Activator, SEK-1*

  1996cited by this paper

• Therapeutic limitations of oncolytic VSVd51-mediated miR-199a-5p delivery in triple negative breast cancer models

  2025cites this paper
• Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks.

  2024cites this paper
• Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example.

  2024cites this paper
• MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway

  2024cites this paper
• Design, synthesis of new 3H-imidazo[4,5-b]pyridine derivatives and evaluation of their inhibitory properties as mixed lineage kinase 3 inhibitors.

  2024cites this paper
• Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis.

  2024cites this paper
• Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC

  2024cites this paper
• TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer

  2023cites this paper
• Suppressing the MLK3 promotes glutamine metabolism: mechanism and implications in progression of colon cancer

  2023cites this paper
• Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives.

  2023cites this paper
• MLK3 Regulates Inflammatory Response via Activation of AP-1 Pathway in HEK293 and RAW264.7 Cells

  2022cites this paper
• Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma

  2022cites this paper
• The role of mixed lineage kinase 3 (MLK3) in cancers.

  2022cites this paper
• MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3

  2021cites this paper
• Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation

  2021cites this paper
• Berberine Represses b -Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells s

  2020cites this paper
• The regulatory function of mixed lineage kinase 3 in tumor and host immunity.

  2020cites this paper
• Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway

  2020cites this paper
• P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer

  2020cites this paper
• Berberine represses β-catenin translation involving 4E-BPs in hepatocellular carcinoma cells.

  2020cites this paper
• DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.

  2019cites this paper
• Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation.

  2019cites this paper
• MLK3 silence induces cervical cancer cell apoptosis via the Notch‐1/autophagy network

  2019cites this paper